Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Equine Matrix Metalloproteinase-9 (MMP9)

Cat. No.AP9C663

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Equine Matrix Metalloproteinase-9 (MMP9) is a recombinant protein expressed from Yeast. Its predicted molecular weight is 69.0 kDa. The purity is>85% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Equine
Expression System Yeast
Purity >85% (SDS-PAGE)
Predicted Molecular Weight 69.0 kDa
Physical State Lyophilized
Formulation The buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose.

Target Information

Equine matrix metalloproteinase-9 (MMP9) is an enzyme that plays a critical role in the breakdown of extracellular matrix in horses. It is involved in physiological processes such as tissue remodeling, wound healing, and immune responses. In veterinary medicine, MMP9 is significant for diagnosing and monitoring inflammatory diseases and musculoskeletal disorders. It can also serve as a biomarker for exercise-induced damage or injury in performance horses.

Protein Equine Matrix Metalloproteinase-9 (MMP9)
Protein Synonym 92 kDa gelatinase; 92 kDa type IV collagenase ; Gelatinase B
Gene ID 100056599

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Aliquot the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket